F10 and acute kidney injury: Introduction: We describe the changes in anti factor Xa (aFXa) activity, thrombin generation and thromboelastography (TEG) in critically ill patients with and without acute kidney injury (AKI) following routine administration of Tinzaparin as part of venous thromboembolism (VTE) prophylaxis.